These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9566672)

  • 1. Soluble intercellular adhesion molecule-1 (sICAM-1) and soluble interleukin-2 receptors (sIL-2R) in scleroderma skin.
    Søndergaard K; Stengaard-Pedersen K; Zachariae H; Heickendorff L; Deleuran M; Deleuran B
    Br J Rheumatol; 1998 Mar; 37(3):304-10. PubMed ID: 9566672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of soluble TNF alpha receptor type I and the severity of systemic sclerosis.
    Majewski S; Wojas-Pelc A; Malejczyk M; Szymanska E; Jablonska S
    Acta Derm Venereol; 1999 May; 79(3):207-10. PubMed ID: 10384918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 2, soluble interleukin 2 receptor, and interferon-gamma in the suction blister fluids from psoriatic skin.
    Takematsu H; Tagami H
    Arch Dermatol Res; 1990; 282(3):149-52. PubMed ID: 2114831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of specific IgE, soluble interleukin-2 receptor, and soluble intercellular adhesion molecule-1 in seasonal allergic rhinitis.
    Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Ohno Y; Masamoto T; Sakamoto H; Kato A; Washio Y; Hayashi M
    Ann Allergy Asthma Immunol; 1997 Sep; 79(3):213-20. PubMed ID: 9305226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased levels of type I and III collagen and hyaluronan in scleroderma skin.
    Søndergaard K; Heickendorff L; Risteli L; Risteli J; Zachariae H; Stengaard-Pedersen K; Deleuran B
    Br J Dermatol; 1997 Jan; 136(1):47-53. PubMed ID: 9039294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical course and changes of soluble interleukin-2 receptor and soluble forms of intercellular adhesion molecule-1 (ICAM-1) in serum of multiple sclerosis patients].
    Bilińska M; Frydecka I; Podemski R
    Neurol Neurochir Pol; 2001; 35(1):47-56. PubMed ID: 11464716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interleukin-2 receptor in lesions and serum of bullous pemphigoid.
    Zillikens D; Ambach A; Schuessler M; Dummer R; Hartmann AA; Burg G
    Arch Dermatol Res; 1992; 284(3):141-5. PubMed ID: 1503497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble adhesion molecules and interleukin-2 receptor concentrations in patients with autoimmune chronic hepatitis.
    Simpson KJ; Jones AL; Forbes Howie A; Hayes PC
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):455-60. PubMed ID: 7542148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated levels of interleukin-2 receptor and intercellular adhesion molecule 1 in sera from a venezuelan cohort of patients with dengue.
    Valero N; Larreal Y; Espina LM; Reyes I; Maldonado M; Mosquera J
    Arch Virol; 2008; 153(1):199-203. PubMed ID: 18080798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased levels of circulating intercellular adhesion molecule-1 in patients with systemic sclerosis.
    Kiener H; Graninger W; Machold K; Aringer M; Graninger WB
    Clin Exp Rheumatol; 1994; 12(5):483-7. PubMed ID: 7842528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating intercellular adhesion molecule-1 in patients with systemic sclerosis.
    Sfikakis PP; Tesar J; Baraf H; Lipnick R; Klipple G; Tsokos GC
    Clin Immunol Immunopathol; 1993 Jul; 68(1):88-92. PubMed ID: 8099861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in Crohn's disease, celiac disease, and systemic lupus erythematosus.
    Srivastava MD; Rossi TM; Lebenthal E
    Res Commun Mol Pathol Pharmacol; 1995 Jan; 87(1):21-6. PubMed ID: 7735726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type III procollagen N-terminal propeptide, soluble interleukin-2 receptor, and von Willebrand factor in systemic sclerosis.
    Lee YJ; Shin KC; Kang SW; Lee EB; Kim HA; Song YW
    Clin Exp Rheumatol; 2001; 19(1):69-74. PubMed ID: 11247328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
    Srivastava MD; Srivastava A; Srivastava BI
    Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized scleroderma.
    Ihn H; Sato S; Fujimoto M; Kikuchi K; Takehara K
    Br J Dermatol; 1996 May; 134(5):843-7. PubMed ID: 8736323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for cell-mediated immune mechanisms in the pathology of pemphigus.
    Zillikens D; Ambach A; Zentner A; Dummer R; Schüssler M; Burg G; Bröcker EB
    Br J Dermatol; 1993 Jun; 128(6):636-43. PubMed ID: 8338748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma.
    Boyano MD; Garcia-Vázquez MD; López-Michelena T; Gardeazabal J; Bilbao J; Cañavate ML; Galdeano AG; Izu R; Díaz-Ramón L; Raton JA; Díaz-Pérez JL
    Br J Cancer; 2000 Oct; 83(7):847-52. PubMed ID: 10970683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble adhesion molecules and cytokines in patients with myasthenia gravis treated by plasma exchange.
    Tesar V; Jelínková E; Jirsa M; Bakosová M; Pitha P; Chábová V
    Blood Purif; 2000; 18(2):115-20. PubMed ID: 10838470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical correlations of potential activity markers in systemic sclerosis.
    Becvár R; Stork J; Pesáková V; Stánová A; Hulejová H; Rysová L; Zatloukalová A; Zatloukal P; Jáchymová M; Pourová L
    Ann N Y Acad Sci; 2005 Jun; 1051():404-12. PubMed ID: 16126982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implication of intercellular adhesion molecule-1 (ICAM-1) and serum N(G)-hydroxy-L-arginine (L-NHA) in the pathogenesis of systemic sclerosis.
    Zamzam ML; Yassin MM; Sallam MM
    Egypt J Immunol; 2003; 10(2):27-38. PubMed ID: 15719609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.